Strengthening Mycoplasma Control in GMP Viral Vector Manufacturing
Viral vectors play an essential role in modern cell and gene therapy, enabling researchers and manufacturers to deliver genetic material into target cells. However, maintaining product quality throughout production requires strict contamination control. Mycoplasma presents a particular challenge because these microorganisms can enter cell cultures without causing obvious changes in appearance or growth. Effective mycoplasma viral vector manufacturing practices help manufacturers protect cell culture integrity, maintain process consistency, and support the production of safe, high-quality viral vector products. As viral vector manufacturing advances toward clinical and commercial applications, manufacturers must integrate contamination prevention, appropriate testing, and documented quality controls into their production strategies. A proactive approach helps identify potential risks early and supports compliance with applicable Good Manufacturing Practice (GMP) requirements. Und...